{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:18:37Z","timestamp":1786587517477,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ctim.2022.102839","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T22:03:06Z","timestamp":1650924186000},"page":"102839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial"],"prefix":"10.1016","volume":"68","author":[{"given":"Yaoliang","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexing","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2022.102839_bib1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomised controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ctim.2022.102839_bib2","unstructured":"Torborg L. Mayo Clinic Q and A: for most diagnosed with it, IBS is a chronic, lifelong condition; 2015. \u3008https:\/\/newsnetwork.mayoclinic.org\/discussion\/mayo-clinic-q-and-a-for-most-diagnosed-with-it-ibs-is-a-chronic-lifelong-condition\/\u3009. [Accessed 20 April 2021]."},{"key":"10.1016\/j.ctim.2022.102839_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2005.02463.x","article-title":"Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact","volume":"21","author":"Hungin","year":"2005","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib4","unstructured":"Quigley E, Fried M, Gwee K, Olano C, Guarner F, Khalif I, et al. Irritable bowel syndrome: a global perspective. World Gastroenterology Organisation Global Guideline; 2009. Page 3. \u3008https:\/\/www.worldgastroenterology.org\/guidelines\/global-guidelines\/irritable-bowel-syndrome-ibs\/irritable-bowel-syndrome-ibs-english\u3009. [Accessed 20 April 2021]."},{"key":"10.1016\/j.ctim.2022.102839_bib5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.clinthera.2006.10.010","article-title":"Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study","volume":"28","author":"Par\u00e9","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00019053-200624010-00002","article-title":"Costs of irritable bowel syndrome in the UK and US","volume":"24","author":"Maxion-Bergemann","year":"2006","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ctim.2022.102839_bib7","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102839_bib8","first-page":"299","article-title":"The burden of illness of irritable bowel syndrome: current challenges and hope for the future","volume":"10","author":"Hulisz","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ctim.2022.102839_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/1756283X17718677","article-title":"The global impact of IBS: time to think about IBS-specific models of care?","volume":"10","author":"Corsetti","year":"2017","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib10","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1572-0241.2001.04680.x","article-title":"Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study","volume":"96","author":"Agr\u00e9us","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.ctim.2022.102839_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","article-title":"The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study","volume":"22","author":"Vahedi","year":"2005","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","article-title":"Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial","volume":"39","author":"Cappello","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ctim.2022.102839_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","article-title":"The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome","volume":"124","author":"Creed","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102839_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102839_bib16","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2008.09.005","article-title":"Challenges to the therapeutic pipeline for irritable bowel syndrome: endpoints and regulatory hurdles","volume":"135","author":"Camilleri","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.ctim.2022.102839_bib17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib18","first-page":"138","article-title":"The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases","volume":"39","author":"Kong","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2036.2006.02776.x","article-title":"Systematic review: complementary and alternative medicine in the irritable bowel syndrome","volume":"23","author":"Hussain","year":"2006","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib20","first-page":"143","article-title":"Complementary and alternative medicine for treatment of irritable bowel syndrome","volume":"55","author":"Shen","year":"2009","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.ctim.2022.102839_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1365-2036.2001.01053.x","article-title":"Herbal treatment in gastrointestinal and liver disease: benefits and dangers","volume":"15","author":"Langmead","year":"2001","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2036.2003.01498.x","article-title":"Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia","volume":"17","author":"Koloski","year":"2003","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6882-8-46","article-title":"Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO","volume":"8","author":"van Tilburg","year":"2008","journal-title":"BMC Complement Alter Med"},{"key":"10.1016\/j.ctim.2022.102839_bib24","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/ajg.2014.108","article-title":"Complementary and alternative medicine use by US adults with gastrointestinal conditions: results from the 2012 National Health Interview Survey","volume":"109","author":"Dossett","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib25","series-title":"Herbal medicine made easy: natural and effective remedies for common illnesses","first-page":"128","author":"Joiner","year":"2001"},{"key":"10.1016\/j.ctim.2022.102839_bib26","first-page":"1614","article-title":"The consensus of traditional Chinese medicine diagnosis of and treatment for irritable bowel syndrome","volume":"58","author":"The Spleen and Stomach subcommittee of China Association of Traditional Chinese Medicine","year":"2017","journal-title":"J Trad Chin Med"},{"key":"10.1016\/j.ctim.2022.102839_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/acm.2006.12.401","article-title":"Effectiveness of the Chinese herbal formula TongXie YaoFang for irritable bowel syndrome: a systematic review","volume":"12","author":"Bian","year":"2006","journal-title":"J Alter Complement Med"},{"key":"10.1016\/j.ctim.2022.102839_bib28","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.cgh.2017.06.026","article-title":"Tongxie formula reduces symptoms of irritable bowel syndrome","volume":"15","author":"Fan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ctim.2022.102839_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.14817","article-title":"Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome","volume":"48","author":"Chen","year":"2018","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.ctim.2022.102839_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ctim.2018.07.002","article-title":"Are personalized tongxie formula based on diagnostic analyses more effective in reducing IBS symptoms? \u2014 a randomised controlled trial","volume":"40","author":"Wang","year":"2018","journal-title":"Complement Ther Med"},{"issue":"15","key":"10.1016\/j.ctim.2022.102839_bib31","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.3748\/wjg.v21.i15.4536","article-title":"Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P","volume":"21","author":"Yin","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12906-019-2749-4","article-title":"Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-\u03baB and notch signalling pathways","volume":"19","author":"Hou","year":"2019","journal-title":"BMC Complement Alter Med"},{"issue":"34","key":"10.1016\/j.ctim.2022.102839_bib33","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.3748\/wjg.v25.i34.5134","article-title":"Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats","volume":"25","author":"Zhao","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib34","unstructured":"Li K, Kuang HX, Yin Y, Zhang JY, Wang Z, Zhang QY, Wang JW. Effect of Tongxie Yaofang on endogenous metabolites in serum of IBS model rats. Zhongguo Zhong Yao Za Zhi, vol. 42(issue 5); 2017, p. 970\u201381. Chinese. \u3008https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20170121.016\u3009. PMID: 28994543."},{"key":"10.1016\/j.ctim.2022.102839_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9086034","article-title":"The effect of Tong-Xie-Yao-Fang on intestinal mucosal mast cells in postinfectious irritable bowel syndrome rats","volume":"2017","author":"Ma","year":"2017","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.ctim.2022.102839_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7954982","article-title":"Effect of TongXie-YaoFang on Cl(-) and HCO3(-) transport in diarrhea-predominant irritable bowel syndrome rats","volume":"2016","author":"Lu","year":"2016","journal-title":"Evid Based Complement Altern Med"},{"issue":"48","key":"10.1016\/j.ctim.2022.102839_bib37","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.3748\/wjg.v22.i48.10584","article-title":"Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel","volume":"22","author":"Yang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102839_bib38","first-page":"1393","article-title":"Section II: FGIDs: diagnostic groups \u2014 bowel disorders","volume":"150","author":"Brian","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102839_bib39","series-title":"Guidance for industry irritable bowel syndrome\u2014clinical evaluation of drugs for treatment. Final guidance","author":"The US Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.ctim.2022.102839_bib40","series-title":"The pharmacopoeia of the People\u2019s Republic of China","author":"The Pharmacopoeia Committee of the Executive Committee","year":"2015"},{"key":"10.1016\/j.ctim.2022.102839_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/03007995.2019.1687432","article-title":"Critical thinking about three meta-analyses: can vitamin D alone or with calcium prevent fractures?","volume":"36","author":"Fan","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ctim.2022.102839_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial","volume":"145","author":"Pimentel","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctim.2022.102839_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12529-012-9241-6","article-title":"Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial","volume":"20","author":"Zernicke","year":"2013","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.ctim.2022.102839_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00365528509089673","article-title":"Irritable bowel syndrome\u2013prognosis and diagnostic safety. A 5-year follow-up study","volume":"20","author":"Svendsen","year":"1985","journal-title":"Scand J Gastroenterol"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:17:32Z","timestamp":1760807852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229922000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"alternative-id":["S0965229922000413"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102839","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102839"}}